Literature DB >> 8359577

Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.

M J Stevens1, S A Lattimer, M Kamijo, C Van Huysen, A A Sima, D A Greene.   

Abstract

Diabetic neuropathy results from progressive nerve fibre damage with blunted nerve regeneration and repair and may be complicated by nerve hyperexcitability resulting in pain. The naturally occurring amino acid taurine functions as an osmolyte, inhibitory neurotransmitter, and modulator of pain perception. It is also known to have neurotrophic actions. The compatible osmolyte hypothesis proposes that levels of intracellular organic osmolytes including taurine and myo-inositol, respond co-ordinately in response to changes in intracellular sorbitol or external osmolality to maintain the intracellular milieu. We hypothesize that glucose-induced sorbitol accumulation in diabetes mellitus will result in taurine depletion in peripheral nerve which may potentially impair nerve regeneration and precipitate neuronal hyperexcitability and pain. This study explored the relationships of taurine, myo-inositol and sorbitol in the rat nerve and their effects on nerve conduction velocity. Osmolyte levels and nerve conduction velocity were determined in sciatic nerve from non-diabetic and streptozotocin-induced diabetic rats, with or without dietary taurine or myo-inositol supplementation. Taurine levels decreased by 31% (p < 0.01) and myo-inositol decreased by 37% (p < 0.05) in diabetic nerve as sorbitol accumulated. Taurine supplementation of diabetic animals did not affect nerve conduction velocity but further reduced nerve myo-inositol levels. Prevention of sorbitol accumulation with the aldose reductase inhibitor sorbinil increased nerve taurine levels by 22% (p < 0.05) when compared with untreated diabetic animals. Thus, we have demonstrated an interdependence of organic osmolytes within the nerve. Abnormal accumulation of one osmolyte results in reciprocal depletion of others. Diabetic neuropathy may be an example of maladaptive osmoregulation, nerve damage and instability being aggravated by taurine depletion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359577     DOI: 10.1007/bf00404069

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

1.  Neuronal and glial systems for gamma-aminobutyric acid metabolism.

Authors:  A Sellström; L B Sjöberg; A Hamberger
Journal:  J Neurochem       Date:  1975-10       Impact factor: 5.372

2.  Characterization and purification of a mammalian osmoregulatory protein, aldose reductase, induced in renal medullary cells by high extracellular NaCl.

Authors:  J J Bedford; S M Bagnasco; P F Kador; H W Harris; M B Burg
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

Review 3.  The sorbitol pathway and the complications of diabetes.

Authors:  K H Gabbay
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

4.  Oxygen free radical effects in sciatic nerve in experimental diabetes.

Authors:  P A Low; K K Nickander
Journal:  Diabetes       Date:  1991-07       Impact factor: 9.461

Review 5.  Calmodulin plays a pivotal role in cellular regulation.

Authors:  W Y Cheung
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

6.  Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.

Authors:  A A Sima; V Bril; V Nathaniel; T A McEwen; M B Brown; S A Lattimer; D A Greene
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

7.  Taurine transport by rabbit kidney brush-border membranes: coupling to sodium, chloride, and the membrane potential.

Authors:  N A Wolff; R Kinne
Journal:  J Membr Biol       Date:  1988-05       Impact factor: 1.843

8.  Taurine behaves as an osmolyte in Madin-Darby canine kidney cells. Protection by polarized, regulated transport of taurine.

Authors:  S Uchida; T Nakanishi; H M Kwon; A S Preston; J S Handler
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

9.  Aldose reductase expression in human diabetic retina and retinal pigment epithelium.

Authors:  S A Vinores; P A Campochiaro; E H Williams; E E May; W R Green; R L Sorenson
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

10.  Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation.

Authors:  D A Greene; S A Lattimer
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

View more
  23 in total

1.  Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.

Authors:  Roman Stavniichuk; Viktor R Drel; Hanna Shevalye; Yury Maksimchyk; Tamara M Kuchmerovska; Jerry L Nadler; Irina G Obrosova
Journal:  Exp Neurol       Date:  2011-04-16       Impact factor: 5.330

2.  Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.

Authors:  Viktor R Drel; Pal Pacher; Martin J Stevens; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2006-01-31       Impact factor: 7.376

3.  Hyperpolarization of the membrane potential in cardiomyocyte tissue slices by the synchronization modulation electric field.

Authors:  Robin Dando; Zhihui Fang; Wei Chen
Journal:  J Membr Biol       Date:  2012-02-23       Impact factor: 1.843

4.  Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

5.  Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathy.

Authors:  Roman Stavniichuk; Hanna Shevalye; Hiroko Hirooka; Jerry L Nadler; Irina G Obrosova
Journal:  Biochem Pharmacol       Date:  2012-01-20       Impact factor: 5.858

6.  Taurine: A therapeutic agent in experimental kidney disease.

Authors:  H Trachtman; J A Sturman
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

7.  The identification of gene expression profiles associated with progression of human diabetic neuropathy.

Authors:  Junguk Hur; Kelli A Sullivan; Manjusha Pande; Yu Hong; Anders A F Sima; Hosagrahar V Jagadish; Matthias Kretzler; Eva L Feldman
Journal:  Brain       Date:  2011-09-16       Impact factor: 13.501

8.  Transcriptional and post-translational modulation of myo-inositol oxygenase by high glucose and related pathobiological stresses.

Authors:  Baibaswata Nayak; Vinay K Kondeti; Ping Xie; Sun Lin; Navin Viswakarma; Kirtee Raparia; Yashpal S Kanwar
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

9.  Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

10.  Changes in human brain glutamate concentration during hypoglycemia: insights into cerebral adaptations in hypoglycemia-associated autonomic failure in type 1 diabetes.

Authors:  Melissa Terpstra; Amir Moheet; Anjali Kumar; Lynn E Eberly; Elizabeth Seaquist; Gülin Öz
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-19       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.